Skip to main content

Rybelsus® (semaglutide) tablets

Rybelsus® (semaglutide) tablets is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Search for Letters

Find documents for this product by entering your search terms in the box below.

Text: double click to edit.

Have a Question?

Request information directly from the Novo Nordisk
Medical Information department.